Title : Evidence for oxazepam as an in vivo probe of UGT2B15: oxazepam clearance is reduced by UGT2B15 D85Y polymorphism but unaffected by UGT2B17 deletion.

Pub. Date : 2009 Nov

PMID : 19916996






8 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Evidence for oxazepam as an in vivo probe of UGT2B15: oxazepam clearance is reduced by UGT2B15 D85Y polymorphism but unaffected by UGT2B17 deletion. Oxazepam UDP glucuronosyltransferase family 2 member B15 Homo sapiens
2 Evidence for oxazepam as an in vivo probe of UGT2B15: oxazepam clearance is reduced by UGT2B15 D85Y polymorphism but unaffected by UGT2B17 deletion. Oxazepam UDP glucuronosyltransferase family 2 member B15 Homo sapiens
3 Evidence for oxazepam as an in vivo probe of UGT2B15: oxazepam clearance is reduced by UGT2B15 D85Y polymorphism but unaffected by UGT2B17 deletion. Oxazepam UDP glucuronosyltransferase family 2 member B15 Homo sapiens
4 Evidence for oxazepam as an in vivo probe of UGT2B15: oxazepam clearance is reduced by UGT2B15 D85Y polymorphism but unaffected by UGT2B17 deletion. Oxazepam UDP glucuronosyltransferase family 2 member B15 Homo sapiens
5 AIMS: Although in vitro studies indicate that oxazepam is an isoform-selective substrate probe for UDP-glucuronosyltransferase 2B15, the utility of this drug as an in vivo probe is uncertain. Oxazepam UDP glucuronosyltransferase family 2 member B15 Homo sapiens
6 The main aim of this study was to determine whether common missense polymorphisms in the UGT2B15 gene (D85Y and K523T) are associated with altered oxazepam pharmacokinetics and pharmacodynamics. Oxazepam UDP glucuronosyltransferase family 2 member B15 Homo sapiens
7 CONCLUSIONS: These results identify UGT2B15 D85Y as a major determinant of oxazepam clearance, and indicate that oxazepam may be useful as an in vivo probe for glucuronidation by UGT2B15. Oxazepam UDP glucuronosyltransferase family 2 member B15 Homo sapiens
8 CONCLUSIONS: These results identify UGT2B15 D85Y as a major determinant of oxazepam clearance, and indicate that oxazepam may be useful as an in vivo probe for glucuronidation by UGT2B15. Oxazepam UDP glucuronosyltransferase family 2 member B15 Homo sapiens